Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
Zainab Fatima, Blair R. A. Reece, J. Suzanne Moore, Robert T. Means
Abstract
Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.
Topics & Concepts
MedicineAutoimmune hemolytic anemiaImmunologyVaccinationAntibodyImmune systemHemolytic anemiaCoronavirus disease 2019 (COVID-19)VirologyInternal medicineDiseaseInfectious disease (medical specialty)Blood groups and transfusionHeparin-Induced Thrombocytopenia and ThrombosisSARS-CoV-2 and COVID-19 Research